Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
97.00    0.00 (0.00%)
Bid:
94.00
Ask:
100.00
Spread: 6.00 (6.383%)
Market Cap: £105.90m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Full Year Trading Update

1 Feb 2022 07:00

RNS Number : 2280A
Inspecs Group PLC
01 February 2022
 

1 February 2022

 

Inspecs Group plc

("Inspecs" or "the Group")

 

Full Year Trading Update

 

Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear (sunglasses, optical frames and lenses) today announces a trading update for the year ended 31 December 2021 ahead of its final results in May 2022.

Highlights:

· Full year trading in line with Board expectations.

· Completed acquisitions of Swedish eyewear company EGO Eyewear Ltd and German distributor BoDe Design.

· Successful purchase of intellectual property including trademarks of Hardy Amies worldwide.

· New state of the art lens manufacturing facility in Gloucester nearing completion and production started end of December 2021.

 

The Group's trading performance for the year despite Covid-19 restrictions was in line with management's expectations delivering Group revenue of $241.0m (2020: $47.4m). The integration of the Group's Eschenbach acquisition in December 2020 is progressing to plan and the business delivered positive trading in 2021. The Group will continue to realise further synergies from the acquisition into 2022.

During the period, the Group completed the strategic acquisitions of Swedish eyewear company EGO Eyewear Ltd, along with its subsidiaries, and of German distributor BoDe Design. Both acquisitions will enhance the Group's brand portfolio and broadens the distribution of products around the world.

Our main markets in Europe and America have proved to be resilient, and early indications show that, despite restrictions in many of the countries in which we operate, the optical market remains open and current trading is in line with expectations for 2022.

· In Asia, our factories maintained production throughout most of the year, despite both supply chain and Covid-19 restrictions.

· Our new facility in Vietnam is now fully operational, and work has started on the design and planning for our third facility in Vietnam on our additional land purchased in 2021.

· The Group continues to work on its wider environmental and sustainability targets. Botaniq, our new sustainable collection manufactured from bio-based materials, has had a successful launch in 2021 and will continue to grow in 2022.

· The Group has won a number of design and green awards, including four red dot awards and the industry Green Award in 2021.

Inspecs trading outlook for 2022 remains positive with growth prospects underpinned by recent acquisitions and multiple opportunities to continue to grow the business across the globe. The management team remains confident that this strategy will continue to deliver sustained growth in 2022 and over the long-term.

 

Robin Totterman, Chief Executive Officer commented:

"The results achieved in 2021 follow on from the hard work our employees put in over the last 12-months and the implementation of our continuing strategy to build a fully integrated global eyewear business. The Group now has over 35 licensed and owned brands available to our customers around the world, and the ability to provide a sustainable one-stop-shop frame and lens package continues to gain momentum.

I remain confident about the Group's ability to continue to grow organically and through acquisition in the long-term and to continue to deliver further positive results for our customers, shareholders and all stakeholders."

 

For further information please contact:

 

Inspecs Group plc

Robin Totterman (CEO)

Chris Kay (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

Adrian Trimmings

Andrew Clark

Lalit Bose

 

Tel: +44 (0) 20 7418 8900

FTI Consulting (Financial PR)

Alex Beagley

Alice Newlyn

Harriet Jackson

 

Tel: +44 (0) 20 3727 1000

 

About Inspecs Group plc

 

INSPECS is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

INSPECS aims to be the leader in eyewear solutions through its vertically-integrated business model and has adopted a three pillar growth strategy to achieve this: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

 

The Group has completed a number of significant acquisitions since its IPO in February 2020. In December 2020, INSPECS acquired Eschenbach, a leading, global, eyewear supplier headquartered in Nuremberg, Germany, which includes the American company Tura. This followed the acquisition of lens maker Norville in July 2020, whereby INSPECS combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. In December 2021 the Group acquired Ego Eyewear, a design and licensing company which uses third party eyewear manufacturers to produce premium fashion brands, and BoDe, a distributor of optical and sunglasses frames principally to the German market.

 

INSPECS customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.

 

INSPECS has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach, the Group's international reach further extends across Europe and the American markets.

 

More information is available at: https://inspecs.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUASKRUUUAOAR
Date   Source Headline
29th Aug 20241:15 pmRNSHolding(s) in Company
27th Aug 20247:00 amRNSNotice of Interim Results
12th Jul 20244:40 pmRNSHolding(s) in Company
12th Jun 20241:59 pmRNSHolding(s) in Company
6th Jun 20241:54 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement
14th May 20241:49 pmRNSPosting of Annual Report and Notice of AGM
23rd Apr 20243:57 pmRNSHolding(s) in Company
19th Apr 20249:35 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSFinal Results
29th Jan 20247:00 amRNSFull Year Trading Update
11th Jan 20242:10 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSTrading Update
20th Sep 202311:14 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSInterim Results
28th Jul 20237:00 amRNSHalf Year Trading Update
15th Jun 20233:36 pmRNSResult of AGM
22nd May 20231:16 pmRNSNotice of AGM
3rd May 20232:42 pmRNSUpdate on Full Year Results
28th Apr 20231:36 pmRNSDirector/PDMR Share Dealing
27th Apr 20237:00 amRNSPreliminary Unaudited Results
19th Apr 202312:24 pmRNSHolding(s) in Company
23rd Mar 20237:00 amRNSHolding(s) in Company
14th Mar 20233:15 pmRNSHolding(s) in Company
30th Jan 20233:18 pmRNSHolding(s) in Company
27th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSFull Year Trading Update
22nd Dec 20227:00 amRNSHolding(s) in Company
21st Dec 20227:00 amRNSHolding(s) in Company
19th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSAppointment of Non-Executive Directors
25th Nov 20224:41 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
11th Nov 202211:05 amRNSSecond Price Monitoring Extn
11th Nov 202211:00 amRNSPrice Monitoring Extension
9th Nov 20223:33 pmRNSHolding(s) in Company
8th Nov 20222:06 pmRNSSecond Price Monitoring Extn
8th Nov 20222:00 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSDirector/PDMR Share Dealing
3rd Nov 20227:00 amRNSDirector/PDMR Share Dealing
31st Oct 20223:05 pmRNSDirector/PDMR Shareholding
28th Oct 20226:25 pmRNSDirector/PDMR Shareholding - Replacement
28th Oct 20223:25 pmRNSDirector/PDMR Shareholding
27th Oct 20222:06 pmRNSSecond Price Monitoring Extn
27th Oct 20222:00 pmRNSPrice Monitoring Extension
27th Oct 20229:05 amRNSSecond Price Monitoring Extn
27th Oct 20229:00 amRNSPrice Monitoring Extension
27th Oct 20227:00 amRNSTrading Update and Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.